Arcutis Biotherapeutics, Inc. 4

Patrick J. Heron filed an amended Form 4 to correct and increase his indirectly held Arcutis Biotherapeutics (ARQT) common stock holdings to 27,448 shares via Frazier Life Sciences X, L.P., with no new transaction reported.

This Form 4/A for Arcutis Biotherapeutics, Inc. is an amendment and does not report a new trade, but corrects a prior filing for reporting person Patrick J. Heron. The amendment clarifies that Heron, through his indirect interest in Frazier Life Sciences X, L.P., beneficially owns 27,448 shares of Arcutis common stock, an increase of 2,646 shares versus what was previously understated due to a scrivener's error. The shares are held of record by Frazier Life Sciences X, L.P., with associated general partners FHMLS X, L.P. and FHMLS X, L.L.C., where Heron is one of two managing members; he disclaims beneficial ownership except to the extent of his pecuniary interest. No purchase, sale, grant, or other transaction occurred in this amendment; it purely corrects the reported ownership balance.

Filing Facts

CIK

1787306

Ticker

ARQT

Form

4

Source Type

sec

Accession

0001628280-26-042961

Alert Tier

4